chr20-34710110-C-G

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_021202.3(TP53INP2):ā€‹c.466C>Gā€‹(p.Leu156Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000126 in 1,266,086 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.000026 ( 0 hom., cov: 32)
Exomes š‘“: 0.000011 ( 0 hom. )

Consequence

TP53INP2
NM_021202.3 missense

Scores

2
2
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.672
Variant links:
Genes affected
TP53INP2 (HGNC:16104): (tumor protein p53 inducible nuclear protein 2) The protein encoded by this gene promotes autophagy and is essential for proper autophagosome formation and processing. In addition, the encoded protein can enhance rDNA transcription by helping in the assembly of the POLR1/RNA polymerase I preinitiation complex. Finally, this protein serves as a transcriptional activator for some genes. [provided by RefSeq, Jul 2016]
NCOA6 (HGNC:15936): (nuclear receptor coactivator 6) The protein encoded by this gene is a transcriptional coactivator that can interact with nuclear hormone receptors to enhance their transcriptional activator functions. This protein has been shown to be involved in the hormone-dependent coactivation of several receptors, including prostanoid, retinoid, vitamin D3, thyroid hormone, and steroid receptors. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jun 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.083789736).
BS2
High AC in GnomAdExome4 at 12 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
TP53INP2NM_021202.3 linkuse as main transcriptc.466C>G p.Leu156Val missense_variant 5/5 ENST00000374810.8
TP53INP2NM_001329429.2 linkuse as main transcriptc.466C>G p.Leu156Val missense_variant 5/5
TP53INP2NM_001329430.2 linkuse as main transcriptc.466C>G p.Leu156Val missense_variant 4/4
TP53INP2NM_001329431.2 linkuse as main transcriptc.466C>G p.Leu156Val missense_variant 5/5

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
TP53INP2ENST00000374810.8 linkuse as main transcriptc.466C>G p.Leu156Val missense_variant 5/51 NM_021202.3 P1

Frequencies

GnomAD3 genomes
AF:
0.0000264
AC:
4
AN:
151736
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000442
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000108
AC:
12
AN:
1114242
Hom.:
0
Cov.:
33
AF XY:
0.0000112
AC XY:
6
AN XY:
535584
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000703
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000743
Gnomad4 OTH exome
AF:
0.0000225
GnomAD4 genome
AF:
0.0000263
AC:
4
AN:
151844
Hom.:
0
Cov.:
32
AF XY:
0.0000270
AC XY:
2
AN XY:
74210
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000442
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000113

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 17, 2022The c.466C>G (p.L156V) alteration is located in exon 5 (coding exon 3) of the TP53INP2 gene. This alteration results from a C to G substitution at nucleotide position 466, causing the leucine (L) at amino acid position 156 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
6.6
DANN
Benign
0.86
DEOGEN2
Benign
0.018
T;T
Eigen
Benign
-0.67
Eigen_PC
Benign
-0.68
FATHMM_MKL
Benign
0.23
N
LIST_S2
Benign
0.54
.;T
M_CAP
Pathogenic
0.31
D
MetaRNN
Benign
0.084
T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Uncertain
2.1
M;M
MutationTaster
Benign
0.99
N;N
PrimateAI
Pathogenic
0.80
T
PROVEAN
Benign
-0.39
N;N
REVEL
Benign
0.056
Sift
Uncertain
0.016
D;D
Sift4G
Benign
0.30
T;T
Polyphen
0.073
B;B
Vest4
0.081
MutPred
0.17
Gain of methylation at R159 (P = 0.1111);Gain of methylation at R159 (P = 0.1111);
MVP
0.15
MPC
1.3
ClinPred
0.060
T
GERP RS
1.9
Varity_R
0.068
gMVP
0.30

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1283359396; hg19: chr20-33297914; API